Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocorrx Inc (OP: BICX )

2.220 UNCHANGED
Streaming Delayed Price Updated: 12:54 PM EDT, Aug 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.220
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 2.220
Today's Range 2.220 - 2.220
52wk Range 2.070 - 5.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Meet BioCorRx: The Biotechnology Firm Taking A Specialized Approach To Treating Addictive Disorders
Brady Granier, President of BioCorRx, Inc. (OTCQB: BICX) was a guest speaker at Benzinga’s All Access On July 15th, 2022. 
Via Benzinga
BioCorRx to Participate in the Benzinga All Access Event on July 15th
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
-43.22%
-43.22%
1 Month
-6.33%
-6.33%
3 Month
-25.25%
-25.25%
6 Month
-36.57%
-36.57%
1 Year
-47.02%
-47.02%

More News

Read More
BioCorRX Inc. Discusses BICX104 Human Trials and 2B3D Metaverse Partnership with The Stock Day Podcast
Via Newsfile
Exposures Product Safety
BioCorRx Announces First Subject Dosed in Phase I Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Via NewMediaWire
Topics Death
Exposures Death
BioCorRx Featured on LiveNOW from FOX
Via NewMediaWire
Exposures Product Safety
BioCorRx to Present at the LD Micro Invitational XII on June 7th
Via NewMediaWire
BioCorRx and 2B3D to Pilot First-of-its-Kind PTSD and Addiction Treatment Solutions for Veterans in Metaverse Setting
Via NewMediaWire
BioCorRx Business Update for the First Quarter of 2022
Via NewMediaWire
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
From Stock News Now
Via AccessWire
BioCorRx Begins Recruitment for Clinical Trial of BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Via NewMediaWire
Exposures Product Safety
BioCorRx to Present at the Planet MicroCap Showcase 2022 in Las Vegas on May 4th
From BioCorRx Inc.
Via AccessWire
BioCorRX Inc. Discusses FDA Approval Process for Implantable Naltrexone Pellet, BICX104, with The Stock Day Podcast
Via Newsfile
Exposures Product Safety
BioCorRx Announces Additional Award of Nearly $100,000 from NIDA for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Via NewMediaWire
Exposures Product Safety
BioCorRx Provides 2021 Year-End Business Update
Via NewMediaWire
BioCorRx to Participate in Two Upcoming Conferences
Via NewMediaWire
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Via NewMediaWire
BioCorRx Announces Orange County Research Center as Clinical Trial Site for First-In-Human Clinical Trial of BICX104
Via NewMediaWire
BioCorRx to Present at the H.C. Wainwright BioConnect 2022 Conference
Via NewMediaWire
BioCorRx Appoints Drug Delivery Expert Jie Shen, Ph.D., to Scientific Advisory Board
Via NewMediaWire
Exposures Product Safety
BioCorRx to Participate in the Benzinga All Access Event on December 2nd
Via NewMediaWire
Exposures Product Safety
BioCorRx Acquires Intellectual Property for Drug Delivery
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioCorRx Provides Business Update for the Third Quarter of 2021
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
2 Penny Stocks Insiders Are Buying
Via Benzinga
BioCorRx Files Patent Application with the Russian Patent Office (Rospatent) for Naltrexone Implant
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
BioCorRx Inc. (BICX) Featured in Virtual Coverage of LD Micro’s Main Event
Via Investor Brand Network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.